Investing
Top 10 Analyst Upgrades and Downgrades (ABT, ARO, BIIB, CELG, CADC, FACT, HBC, LMNX, EDU, SGI)
Published:
Last Updated:
These are this Friday’s top analyst upgrades, downgrades, and initiations seen from Wall Street morning research calls:
Abbott Laboratories (NYSE: ABT) Cut to Sell at Citigroup.
Aeropostale (NYSE: ARO) Raised to Neutral at Piper Jaffray.
Biogen Idec (NASDAQ: BIIB) Started as Neutral at Piper Jaffray.
Celgene (NASDAQ: CELG) Started as Overweight at Piper Jaffray.
China Advanced Construction Materials (NASDAQ: CADC) Started as Buy at Roth Capital.
Facet Biotech (NASDAQ: FACT) Cut to Market Perform at BMO Capital.
HSBC (NYSE: HBC) Cut to Neutral at Goldman Sachs.
Luminex (NASDAQ: LMNX) Started as Buy at Jefferies.
New Oriental Education (NYSE: EDU) Started as Buy at Deutsche Bank.
Pacific Sunwear of California (NASDAQ: PSUN) Cut to Market Perform at FBR.
Silicon Graphics International (NYSE: SGI) Started as Market Perform at Morgan Keegan.
You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.
JON C. OGG
Credit card companies are at war, handing out free rewards and benefits to win the best customers. A good cash back card can be worth thousands of dollars a year in free money, not to mention other perks like travel, insurance, and access to fancy lounges. Our top pick today has pays up to 5% cash back, a $200 bonus on top, and $0 annual fee. Click here to apply before they stop offering rewards this generous.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.